福永 興壱

Medicine & Life Sciences

1. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 15%
2. Acute Lung Injury 24%
3. Adenocarcinoma of Lung 18%
4. Adrenal Cortex Hormones 18%
5. Advisory Committees 23%
6. Alveolar Epithelial Cells 18%
7. Asthma 70%
8. Bronchoalveolar Lavage Fluid 20%
9. Chronic Obstructive Pulmonary Disease 40%
10. Coronavirus 100%
11. Cyclooxygenase 2 16%
12. cysteinyl-leukotriene 16%
13. Cytokines 13%
14. Emphysema 12%
15. Eosinophils 40%
16. Infections 14%
17. Inflammation 38%
18. Japan 52%
19. Lipopolysaccharides 13%
20. lipoxin A4 14%
21. Lung 63%
22. Lung Diseases 27%
23. Lung Injury 13%
24. Lung Neoplasms 26%
25. Lymphocytes 13%
26. Meta-Analysis 13%
27. Multicenter Studies 15%
28. Mycobacterium avium Complex 38%
29. Non-Small Cell Lung Carcinoma 35%
30. Obstructive Sleep Apnea 19%
31. Ovalbumin 14%
32. Phenotype 15%
33. Platelet Activating Factor 19%
34. Pneumonia 42%
35. pranlukast 14%
36. presqualene pyrophosphate 18%
37. prostaglandin D2 receptor 15%
38. Respiratory Function Tests 15%
39. SARS Virus 29%
40. Serum 18%
41. Severe Acute Respiratory Syndrome 23%
42. Smartphone 15%
43. Smoke 20%
44. Smoking Cessation 13%
45. Standing Position 22%
46. Supine Position 19%
47. Systematic Reviews 12%
48. Therapeutics 24%
49. Tobacco Products 21%
50. Tomography 26%